Discovery could be key to reducing leukemia treatment resistance

In a world first, Newcastle researchers have discovered the mechanisms acute myeloid leukemia (AML) cells use to produce “free radicals”—the byproduct of a cell process that aggressively fuels the growth of cancer cells and limits the effectiveness of current treatments.

Leave A Comment

Your email address will not be published. Required fields are marked *